480 completed. 480 Phase 2, 62 Phase 1, 44 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 480 | Completed 480 |
| Phase 1 | 62 | Completed 62 |
| Phase 3 | 44 | Completed 44 |
Follow Gastroenteritis: new trials by email Literature Review of Gastroenteritis trials Research Report on Gastroenteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants. Shigella4V2, MenACWY - Shigellosis | Phase 2 | Completed | LimmaTech Biologics AG | 110 | 2025-04-07 | 2026-08-07 |
| Effect of Rutin on Inflammation Pathways in Ulcerative Colitis Patients Rutin 500 MG Oral Tablet, Fecal Calprotectin, Placebo - Ulcerative Colitis | Phase 2 | Completed | Benha University | 60 | 2025-02-22 | 2026-01-27 |
| A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis AC-101 - Ulcerative Colitis | Phase 1 / Phase 2 | Completed | Accro Bioscience (Suzhou) Limited | 25 | 2025-01-20 | 2026-10-28 |
| A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants altSonflex1-2-3 Dose A, altSonflex1-2-3 Dose B, altSonflex1-2-3 Dose C - Diarrhoea | Phase 2 | Completed | GlaxoSmithKline | 200 | 2024-11-13 | 2026-10-26 |
| A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine Shigella4V2, Placebo - Shigellosis | Phase 2 | Completed | LimmaTech Biologics AG | 97 | 2024-11-12 | 2026-10-01 |
| Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA) Piperacillin/tazobactam, Normal saline, CefTRIAXone Injection - Appendicitis Perforated | Phase 2 | Completed | McMaster Children's Hospital | 16 | 2024-09-09 | 2026-07-07 |
| Racecadotril Versus Standard Treatment in Decreasing the Duration of Acute Diarrhoea in Children Racecadotril - Diarrhoea | Phase 1 / Phase 2 | Completed | Benazir Bhutto Hospital, Rawalpindi | 260 | 2024-08-02 | 2026-09-22 |
| Trial of Mirtazapine for Depression in IBD Mirtazapine, Placebo - Major Depressive Disorder, Inflammatory Bowel Diseases | Phase 2 | Completed | King's College London | 76 | 2024-05-07 | 2026-08-19 |
| The Effects of Bromelain Supplement in Patients With Ulcerative Colitis Bromlein, Placebo - Ulcerative Colitis, Primary Sclerosing Cholangitis | Phase 2 / Phase 3 | Completed | National Nutrition and Food Technology Institute | 52 | 2024-04-20 | 2026-10-27 |
| A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates Arm1, Arm 2 - Ulcerative Colitis | Phase 2 | Completed | Zydus Lifesciences Limited | 24 | 2024-04-08 | 2024-12-20 |
| Minocyclin in Ulcerative Colitis as Added on Therapy Mesalazine, Minocycline - Inflammatory Bowel Diseases | Phase 2 | Completed | Mostafa Bahaa | 46 | 2024-01-22 | 2025-11-18 |
| Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer Pentoxifylline 400mg plus chemotherapy, Chemotherapy - Breast Cancer Female, Breast Cancer Patients | Phase 2 | Completed | Mansoura University | 100 | 2023-12-25 | 2025-07-28 |
| Comparison Between the Effect of Aloe Vera and Benzydamine Hydrochloride Mouth Gel on Prevention of Pain and Progression of Radiation-induced Oral Mucositis Aloe vera gel, Benzydamine Hydrochloride 0.15% Oral gel, bioadhesive gel - Radiation Indused Oral Mucositis | Phase 1 / Phase 2 | Completed | Minia University | 30 | 2023-11-01 | 2025-03-06 |
| A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis JNJ-77242113, Placebo - Colitis, Ulcerative | Phase 2 | Completed | Janssen Research & Development, LLC | 252 | 2023-10-09 | 2026-04-13 |
| Dapagliflozin in Patients With Ulcerative Colitis Mesalamine, Dapagliflozin 10mg Tab - Inflammatory Bowel Diseases | Phase 2 / Phase 3 | Completed | Mostafa Bahaa | 60 | 2023-08-20 | 2026-09-21 |
| Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis Mesalamine, Nifuroxazide - Inflammatory Bowel Diseases | Phase 2 / Phase 3 | Completed | Mostafa Bahaa | 50 | 2023-08-20 | 2026-10-13 |
| Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults HIL-214 - Gastroenteritis | Phase 2 | Completed | HilleVax | 80 | 2023-08-01 | 2025-08-19 |
| Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines HIL-214, Placebo - Gastroenteritis | Phase 2 / Phase 3 | Completed | HilleVax | 329 | 2023-06-10 | 2025-03-12 |
| A Study of CDX-0159 in Patients With Eosinophilic Esophagitis barzolvolimab, Matching Placebo - Eosinophilic Esophagitis | Phase 2 | Completed | Celldex Therapeutics | 86 | 2023-06-01 | 2026-05-27 |
| Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model. Travelan, Placebo - Diarrhea, Travelers Diarrhea | Phase 2 | Completed | Immuron Ltd. | 63 | 2023-05-29 | 2026-06-12 |
Showing 20 of 480. Sign in to see all of them.
Colitis, Ulcerative (153) · Crohn Disease (146) · Inflammatory Bowel Diseases (71) · Mucositis (40) · Eosinophilic Esophagitis (34) · Esophagitis (17) · Dysentery, Bacillary (16) · Enterocolitis, Necrotizing (15) · Head and Neck Neoplasms (12) · Stomatitis (12) · Colitis (11) · Appendicitis (10) · Diarrhea (9) · Enterocolitis, Pseudomembranous (9)
Digestive System Diseases (474) · Gastrointestinal Diseases (473) · Intestinal Diseases (376) · Inflammatory Bowel Diseases (234) · Colonic Diseases (161) · Colitis (147) · Infections (55) · Pathological Conditions, Signs and Symptoms (54) · Immune System Diseases (51) · Hemic and Lymphatic Diseases (47) · Esophageal Diseases (43) · Hematologic Diseases (42) · Stomatognathic Diseases (41) · Leukocyte Disorders (40)
Fecal Microbiota Transplantation (15) · Mesalamine (13) · Budesonide (9) · Metronidazole (7) · Saline Solution (6) · Sodium Chloride (6) · Vancomycin (6) · vedolizumab (6) · Adalimumab (5) · Certolizumab Pegol (5) · Fluticasone (5) · etrasimod (5) · spesolimab (5) · tofacitinib (5) · ABX464 (4)
Pfizer (14) · GlaxoSmithKline (11) · AbbVie (9) · Shire (9) · Children's Hospital Medical Center, Cincinnati (8) · Janssen Research & Development, LLC (7) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Tanta University (7) · Bristol-Myers Squibb (6) · Dr. Falk Pharma GmbH (6) · Facet Biotech (6) · Mayo Clinic (6) · Amgen (5) · Boehringer Ingelheim (5) · University of Alberta (5)
United States (231) · Canada (99) · Germany (90) · Poland (85) · Belgium (74) · Hungary (73) · France (64) · United Kingdom (60) · Czechia (58) · Netherlands (58) · Spain (53) · Israel (47) · Italy (46) · Ukraine (43) · Australia (40)
Dina Kao, MD (5) · Marc E Rothenberg, MD, PhD (4) · Arena CT.gov Administrator (3) · Daan Hommes, MD (3)
PMID 30721964, PMID 21871249, PMID 22325170, PMID 26893500, PMID 28209624, PMID 29247068, PMID 30113844, PMID 30739254, PMID 38863178, PMID 39778975, PMID 10440607, PMID 11171619, PMID 11427329, PMID 11692292, PMID 12809830, PMID 15017618, PMID 16984503, PMID 17382603, PMID 17560413, PMID 17636753, PMID 17920064, PMID 17975182, PMID 18325386, PMID 18623174, PMID 18706417, PMID 18809665, PMID 18829392, PMID 18952896, PMID 18973181, PMID 19145731, PMID 19208097, PMID 19358184, PMID 19421322, PMID 19505878, PMID 19634161, PMID 19714757, PMID 19828470, PMID 19842970, PMID 19885903, PMID 20004787, PMID 20048683, PMID 20086085, PMID 20412178, PMID 20413687, PMID 20457157, PMID 20542323, PMID 20736987, PMID 20980771, PMID 21050319, PMID 21332762
2016 (12), 2017 (10), 2018 (8), 2014 (6), 2015 (5), 2023 (4), 2009 (3), 2019 (3), 2008 (2), U54AI117804 (2), K23DE016946 (1), K23DK073750 (1), K23DK109136 (1), P30CA006516 (1), P30CA015083 (1)